Log in

Sientra Stock Forecast, Price & News

+0.07 (+1.39 %)
(As of 12/3/2020 12:00 AM ET)
Today's Range
Now: $5.11
50-Day Range
MA: $4.69
52-Week Range
Now: $5.11
Volume813,212 shs
Average Volume1.12 million shs
Market Capitalization$257.82 million
P/E RatioN/A
Dividend YieldN/A
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, OPUS, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
Sientra logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.62 out of 5 stars

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Current SymbolNASDAQ:SIEN



Sales & Book Value

Annual Sales$83.70 million
Book Value$1.65 per share


Net Income$-106,820,000.00
Net Margins-140.76%


Market Cap$257.82 million
Next Earnings Date3/10/2021 (Estimated)
+0.07 (+1.39 %)
(As of 12/3/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SIEN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIEN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Sientra (NASDAQ:SIEN) Frequently Asked Questions

How has Sientra's stock price been impacted by COVID-19?

Sientra's stock was trading at $2.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SIEN stock has increased by 109.4% and is now trading at $5.11.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Sientra?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Sientra
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Sientra?

Wall Street analysts have given Sientra a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sientra wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Sientra's next earnings date?

Sientra is scheduled to release its next quarterly earnings announcement on Wednesday, March 10th 2021.
View our earnings forecast for Sientra

How were Sientra's earnings last quarter?

Sientra, Inc. (NASDAQ:SIEN) announced its quarterly earnings data on Monday, November, 9th. The medical instruments supplier reported ($0.12) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.38) by $0.26. Sientra had a negative net margin of 140.76% and a negative return on equity of 130.33%.
View Sientra's earnings history

What guidance has Sientra issued on next quarter's earnings?

Sientra updated its FY 2020 After-Hours earnings guidance on Monday, November, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $63-66 million, compared to the consensus revenue estimate of $61.31 million.

What price target have analysts set for SIEN?

6 brokers have issued 12-month price objectives for Sientra's shares. Their forecasts range from $5.00 to $9.00. On average, they expect Sientra's stock price to reach $7.20 in the next year. This suggests a possible upside of 40.9% from the stock's current price.
View analysts' price targets for Sientra

Are investors shorting Sientra?

Sientra saw a increase in short interest in October. As of October 30th, there was short interest totaling 3,100,000 shares, an increase of 21.6% from the October 15th total of 2,550,000 shares. Based on an average daily trading volume, of 725,900 shares, the days-to-cover ratio is currently 4.3 days. Approximately 7.1% of the shares of the stock are short sold.
View Sientra's Short Interest

Who are some of Sientra's key competitors?

What other stocks do shareholders of Sientra own?

Who are Sientra's key executives?

Sientra's management team includes the following people:
  • Mr. Jeffrey M. Nugent, Chairman & CEO (Age 73, Pay $1.92M)
  • Mr. Paul Sean Little, CFO, Sr. VP & Treasurer (Age 55, Pay $513.65k)
  • Mr. Charles Huiner, Consultant (Age 49, Pay $558.46k)
  • Mr. Keith J. Sullivan, Director & Advisor to MiraDry Bus. (Age 62, Pay $40k)
  • Mr. Jeffrey S. Jones, VP of Operations (Age 64)
  • Ms. Deborah Bettencourt, VP of HR & Corp. Admin.
  • Mr. Oliver Christian Bennett, Gen. Counsel and VP of Compliance & Legal
  • Mr. Kirk Gunhus, Sr. VP of Worldwide Sales
  • Ms. Lisa Rosas, VP of Marketing
  • Ms. Valerie J. Miller, VP & Corp. Controller (Age 56)

What is Sientra's stock symbol?

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Who are Sientra's major shareholders?

Sientra's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.28%), Royce & Associates LP (1.57%), State Street Corp (1.53%), JPMorgan Chase & Co. (1.36%), Morgan Stanley (0.92%) and X Square Capital LLC (0.58%). Company insiders that own Sientra stock include Jeffrey M Nugent, Keith J Sullivan and Paul Sean Little.
View institutional ownership trends for Sientra

Which major investors are selling Sientra stock?

SIEN stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Assenagon Asset Management S.A., BlackRock Inc., X Square Capital LLC, and Charles Schwab Investment Management Inc..
View insider buying and selling activity for Sientra

Which major investors are buying Sientra stock?

SIEN stock was bought by a variety of institutional investors in the last quarter, including Royce & Associates LP, Morgan Stanley, Squarepoint Ops LLC, ExodusPoint Capital Management LP, OLD Mission Capital LLC, Raymond James Financial Services Advisors Inc., Raymond James & Associates, and State Street Corp. Company insiders that have bought Sientra stock in the last two years include Keith J Sullivan, and Paul Sean Little.
View insider buying and selling activity for Sientra

How do I buy shares of Sientra?

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sientra's stock price today?

One share of SIEN stock can currently be purchased for approximately $5.11.

How big of a company is Sientra?

Sientra has a market capitalization of $257.82 million and generates $83.70 million in revenue each year. The medical instruments supplier earns $-106,820,000.00 in net income (profit) each year or ($2.29) on an earnings per share basis. Sientra employs 339 workers across the globe.

What is Sientra's official website?

The official website for Sientra is www.sientra.com.

How can I contact Sientra?

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]

This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.